Physician profile
Mark B Wagner
NPI 1891710869
$9,583.75
in general payments reported to CMS, 2019-2025
18 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,726 · 2020: $1,517 · 2021: $597 · 2022: $3,542 · 2023: $225 · 2024: $731 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,124 · Food and Beverage: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,124.04 |
| Food and Beverage | $1,078.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $2,348.16 | 2020-2023 | |
| Stryker Corporation | $2,324.52 | 2019-2025 | Mako, Aequalis |
| Arthrex, INC. | $2,296.84 | 2020-2022 | |
| Smith+Nephew, INC. | $2,164.36 | 2019-2025 | Stravix, Stravix Mesh, Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $77.84 | 2019-2024 | Tapestry |
| Exsomed Corporation | $62.58 | 2021 | |
| Sanofi-Aventis U.S. LLC | $60.84 | 2019-2023 | |
| Orthalign INC | $35.00 | 2019 | |
| Bioventus LLC | $31.28 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $31.26 | 2020-2022 | |
| Pacira Therapeutics, INC. | $30.04 | 2019 | |
| Avanos Medical | $28.92 | 2019-2025 | On-Q Pump and Accessories |
| Coopersurgical, INC. | $18.68 | 2019 | |
| Medtronic Vascular, INC. | $18.67 | 2020 | |
| Abbott Laboratories | $16.49 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $13.49 | 2025 | Perclot |
| Heron Therapeutics, INC. | $13.17 | 2022 | |
| Convatec INC. | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.